Associated Papers
Analysis of the Italian cohort of late-onset Pompe disease (LOPD) patients after 10 and 15 years of therapy with alglucosidase alfa.
Mongini T et al.
Journal of Neurology, 2025
Clinical and therapeutic clues from a long-term follow-up: a single center experience on a large LOPD population.
Pugliese A et al.
Journal of Neurology, 2025
GAA variants and phenotypes among 1,079 patients with Pompe disease: Data from the Pompe Registry.
Reuser AJJ et al.
Human Mutation, 2019
Central nervous system involvement in late-onset Pompe disease: clues from neuroimaging and neuropsychological analysis.
Musumeci O et al.
European Journal of Neurology, 2019
Late-onset Pompe disease: a genetic-radiological correlation on cerebral vascular anomalies.
Pichiecchio A et al.
Journal of Neurology, 2017
Intracranial arterial abnormalities in patients with late onset Pompe disease (LOPD).
Montagnese F et al.
Journal of Inherited Metabolic Disease, 2016
Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment.
Montagnese F et al.
Journal of Neurology, 2015
Molecular pathology and enzyme processing in various phenotypes of acid maltase deficiency.
Nascimbeni AC et al.
Neurology, 2008
Frequency of Cerebrovascular Abnormalities in Patients with Late-Onset Pompe Disease: Our Experience.
Sancricca C et al.
Journal of Neuromuscular Diseases, 0
Select a paper to view details